A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Majdolen Istaiti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Gaucher Disease, Multiple Myeloma, Lymphoma, Databases, Factual. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Gaucher disease (GD) has been variably associated with cancer risk, with conflicting reports in the literature. Understanding the true cancer burden is critical for patient care and genetic counselling.
Aim
To determine the overall and site‐specific cancer risk in a large, single‐centre GD cohort over three decades.
Methods
This is a retrospective cohort study based at a national referral centre. Medical records of 709 GD patients aged >20 years at Shaare Zedek Medical Center were reviewed. Cancer diagnoses were confirmed using the Israel National Cancer Register. Cancer‐free survival was estimated via Kaplan–Meier analysis. Standardised incidence ratios (SIRs) compared observed versus expected cancer cases.
Results
Sixty‐four (9%) patients were diagnosed with cancer. The most common malignancies were breast, non‐Hodgkin lymphoma (NHL) and colon cancer. The overall incidence was 3.7 (95% confidence interval (CI): 2.6–4.8) per 1000 person‐years. Cancer risk correlated with age but not gender, genotype, splenectomy status or GD therapy. The overall SIR was 0.9 (95% CI: 0.6–1.1), indicating no increased overall cancer risk. However, SIRs for haematological malignancies, including NHL and multiple myeloma, were elevated.
Conclusions
GD patients do not have an increased general cancer risk, though vigilance for haematological malignancies is warranted. Previous literature might have overestimatee risk due to selection bias. These findings support tailored screening strategies and may alleviate patient concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.
- Braun School of Public Health and Community Medicine, Hebrew University, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University, Jerusalem, Israel.
- The Israel National Cancer Register (INCR), Ministry of Health, Jerusalem, Israel.
ORCID-Profile: Majdolen Istaiti, Tama Dinur, Shoshana Revel-Vilk
Zitieren
APA
Istaiti, M., Dinur, T., Paltiel, O., Silverman, B., Revel-Vilk, S., & Zimran, A. (2025). A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours. Internal Medicine Journal. https://doi.org/10.1111/imj.70221
Vancouver
Istaiti M, Dinur T, Paltiel O, Silverman B, Revel-Vilk S, Zimran A. A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours. Internal Medicine Journal. 2025. doi:10.1111/imj.70221
BibTeX
@article{Istaiti2025,
author = {Istaiti, Majdolen and Dinur, Tama and Paltiel, Ora and Silverman, Barbara and Revel-Vilk, Shoshana and Zimran, Ari},
title = {A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70221}
}
EUVIMED